Courtesy moneycontrol.com
Wednesday, February 3, 2010
Dishman Pharmaceuticals & Chemicals NSE NOTICES
Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that the Board of Directors of the Company has, in its meeting held on January 12, 2010, approved the proposal of issue of Non- Convertible Debentures (NCD) up to an amount of INR 750 million, for augmenting medium to long term resources of the Company, including regular capital expenditure.
Source: NSECourtesy moneycontrol.com
Also check
Labels:
Dishman Pharma,
Notices NSE,
NSE
Subscribe to:
Post Comments (Atom)

No comments:
Post a Comment